Products

Synonyms:

● Heparin sodium salt

● Sodium heparinate

● Sodium heparinate

● Heparin sodium salt

● Ardeparin sodium

● Dalteparin Sodium

● Tinzaparin Sodium

● Fragmin

● Sodium Heparin

SPECIFICATION:

Appearance: A white or almost white powder,very hygroscopic

Solubility: Freely soluble in water
Heparin Sodium is Heparin Sodium sulfate glycosaminoglycan anticoagulants.Heparin is from pigs or cows in the intestinal mucosa of extraction of amino dextran sulfate sodium salt, mucopolysaccharide material.In recent years, studies have shown that heparin and fall hematic fat action.

Packaging Details: 25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging ;
aluminium bag outside and double plastic bag inside;
Delivery Detail: Within 3 days when get the payment.
Shipping: We have Professional shipping agent, based on customers ‘ demand for transport
By express: FEDEX,DHL,EMS ,UPS,TNT ect.
By SEA and By AIR
Packing: 25kg/drum 5kg/tin or per customers’requirement
Factory Supply Ability: 120 kgs/year
Lead time: within 3-5 days
Payment Terms： TT LC DP
Sample：sample is available

Transport：

*sample by express, such as Fedex, DHL, EMS, TNT

*small quantity by air

*big quantity by sea

Mainly export to : India, USA, Russia, Turkey, Africa, Pakistan, Kazakhstan, Ghana, etc.

Pharmaceutical Raw Material API Manufacturer and Supplier in China

Factory Name: Jiangxi Runquankang Biological Technology Co., Ltd.

Factory Address: Industrial Park of Guantian town, Chongyi county, Ganzhou city, Jiangxi Province, China.

Registered Capital: RMB50,000,000.00

Factory Area: 15,700 square meters

Employee: 99

Main Pharmacutical raw material, APIs:

Chloramphenicol， Dl-chloramphenicol, Sodium Saccharin，Heparin Sodium,  Bilirubin, Caffeine anhydrous, Theophylline anhydrous , Aminophylline anhydrous.

Packing photos:

Usage:

1.The treatment of various diseases concurrent disseminated intravascular coagulation early.
2. Prevention of arterial and venous thrombosis and pulmonary embolism.
3.Treatment of arterial and venous thrombosis and pulmonary embolism, ischemic stroke, unstable angina (to alleviate the symptoms, prevention of myocardial infarction), acute myocardial infarction (prevention of early reinfarction and infarct extension, reduce mortality).
4.The artificial lung, peritoneal dialysis or hemodialysis as anticoagulants.
5.thrombolytic therapy as maintenance therapy.
6.used for the prevention of blood coagulation and blood bank transfusion of blood and other body save anticoagulants.